Skip to main content

Venetoclax

In Patients with RRMM, Cobimetinib as a Single Agent and Combined with Venetoclax with or without Atezolizumab

In Patients with RRMM, Treatment with Venetoclax plus Daratumumab and Dexamethasone ± Bortezomib

BELLINI Study: Venetoclax versus Placebo in Combination with Bortezomib/Dexamethasone in Patients with RRMM

Venetoclax plus Standard Intensive AML Induction/Consolidation with FLAG-IDA in Patients with Newly Diagnosed or Relapsed/Refractory AML

Decitabine + Venetoclax versus Intensive Chemotherapy for Patients with Relapsed/Refractory AML: A Propensity Score–Matched Analysis

Comparative Effectiveness of Glasdegib or Venetoclax in Combination with Low-Dose Cytarabine Using Simulated Treatment Comparisons

Phase 1b/2 Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Hematologic Malignancies

Venetoclax Added to Cladribine plus Low-Dose Ara-C Alternating with 5-Azacitidine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Phase 2 Study of CPX-351 plus Venetoclax in Patients with Acute Myeloid Leukemia

Decitabine + Venetoclax Compared with Intensive Chemotherapy in AML: A Propensity Score–Matched Analysis

1
2
3

Page 2 of 3
Results 11 - 20 of 26